Metabolic Syndrome Clinical Trial
Official title:
Treadmill Exercise in Metabolic Syndrome
Verified date | May 2022 |
Source | Beth Israel Deaconess Medical Center |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The main purpose of this study is to better understand the effects of two types of treadmill exercise programs that include education and/or techniques that may be helpful for exercise among individuals with, or at risk for, metabolic syndrome.
Status | Terminated |
Enrollment | 12 |
Est. completion date | October 20, 2021 |
Est. primary completion date | July 7, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: 1. Referred by healthcare provider and given medical clearance for moderate-intensity exercise 2. Metabolic syndrome, defined as meeting three or more of the following criteria: - Obesity or overweight defined as BMI > 25 - Impaired glycemia (fasting blood sugar of = 100 [5.6 mmol/L] or glycated hemoglobin [A1C] of = 5.7) - Increased blood pressure (130/85 mmHg or higher) or if you take medicine for high blood pressure - Increased fasting levels of triglycerides (= 150 or 1.7 mmol/L) or decreased fasting high-density lipoprotein (HDL) cholesterol (less than 40 mg/dL or 1 mmol/L for men or 50 mg/dL or 1.3 mmol/L for women) or if you take any medicines for dyslipidemia 3. Between the ages of 18-65 4. No regular physical activity (= 3 or more days per week) for the past 3 months Exclusion Criteria: 1. Contraindications for treadmill exercise determined by their physician (e.g., cardiopulmonary limitations or diagnoses) or other inability to do treadmill exercise (e.g., musculoskeletal restrictions or severe balance impairment) 2. Confirmed diagnosis of coronary artery disease 3. Confirmed diagnosis of diabetes 4. Currently taking a beta blocker or calcium channel blocker medication 5. Uncontrolled and untreated hypertension, defined as a resting blood pressure of 150/90 6. Confirmed diagnosis of chronic obstructive pulmonary disease or other severe lung dysfunction that may interfere with exercise (e.g., severe asthma) 7. Self-reported psychotic disorder 8. Current practice of mindfulness mediation or mindful movement (e.g., yoga or tai chi), defined as regular daily practice or >2 classes or self-guided sessions per week in the past three months. 9. Non-English speaking |
Country | Name | City | State |
---|---|---|---|
United States | BIDMC | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Beth Israel Deaconess Medical Center |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Recruitment Feasibility | % willing to be randomized | Through study completion, an average of 1 year | |
Primary | Protocol Adherence | % sessions attended | Through study completion, an average of 1 year | |
Secondary | Cardiopulmonary Dynamics | CardioPulmonary Exercise Testing (standard metabolic cart) | Weeks 1 and 6 | |
Secondary | Fatigue | Fatigue Severity Scale-7; total score range: 7-49, higher scores = greater fatigue severity | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Global Health | PROMIS Global Health-10; Global physical health total score range: 4-20, higher scores = better global physical health | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Psychological Symptoms | Depression Anxiety and Stress Scale-21; Depression total score range: 0-21, higher scores = greater depressive symptoms | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Affect | Positive and Negative Affect Schedule; 2 subscales; each with score range 10-50, higher = greater positive or negative affect | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Anxiety Sensitivity | Anxiety Sensitivity Index-3; Total score range: 0-72, higher scores = higher levels of anxiety sensitivity | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Distress Tolerance | Distress Tolerance Scale; total score range: 15-75, higher scores = higher levels of distress tolerance | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Discomfort Intolerance | Discomfort Intolerance Scale-Revised; total score range: 0-126, higher scores = higher levels of discomfort intolerance | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Physical Activity Acceptance | Physical Activity Acceptance Questionnaire; total score range: 10-70, higher scores = greater physical activity acceptance | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Exercise Self-Efficacy | Multidimensional Self-Efficacy Scale; total score range: 0-90, higher scores = higher levels of exercise self-efficacy | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Exercise Motivation | Behavioral Regulation towards Exercise Questionnaire-2; 5 subscales, each with score range: 0-16, higher scores = higher levels of regulation | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Exercise Barriers | Exercise Benefits and Barriers Scale; 2 subscales; Exercise benefits subscale score range: 29-116, higher scores = higher perceived benefit from exercise; Exercise barriers subscale score range: 14-56, higher scores = higher perceived barriers to exercise | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Physical Activity | Godin Leisure Time Exercise Questionnaire; open-ended responses, higher scores = greater activity time | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | Trait Mindfulness | Five Facet Mindfulness Questionnaire; 5 subscales; Observe subscale score range: 8-40, higher scores = greater observing skills; Describe subscale score range: 8-40, higher scores = greater describing skills; Acting with Awareness subscale score range: 8-40, higher scores = greater awareness skills; Nonjudgment subscale score range: 8-40, higher scores = greater nonjudgment skills; Nonreactivity subscale score range: 7-35, higher scores = greater nonreactivity skills | Week 0, week 3, post-intervention (after 6 week intervention) | |
Secondary | State Mindfulness | State Mindfulness Scale for Physical Activity; 2 subscales, each with score range: 0-24, higher scores = higher levels of mindfulness | Weeks 1, 3, 6 | |
Secondary | Interoceptive Awareness | Multidimensional Assessment of Interoceptive Awareness; 8 subscales, each with score ranges: 0-5, higher scores = better | Week 0, week 3, post-intervention (after 6 week intervention) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04635202 -
Effect of Elliptical Training on Metabolic Homeostasis in Metabolic Syndrome
|
N/A | |
Completed |
NCT04053686 -
An Intervention to Reduce Prolonged Sitting in Police Staff
|
N/A | |
Completed |
NCT05343858 -
Pilot Study to Evaluate the Effect of Two Microalgae Consumption on Metabolic Syndrome
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Recruiting |
NCT05040958 -
Carotid Atherosclerotic Plaque Load and Neck Circumference
|
||
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Active, not recruiting |
NCT02500147 -
Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)
|
Phase 4 | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Completed |
NCT03289897 -
Non-invasive Rapid Assessment of NAFLD Using Magnetic Resonance Imaging With LiverMultiScan
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Completed |
NCT06057896 -
Effects of Combined Natural Molecules on Metabolic Syndrome in Menopausal Women
|
||
Active, not recruiting |
NCT03613740 -
Effect of Fucoxanthin on the Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion
|
Phase 2 | |
Completed |
NCT04498455 -
Study of a Prebiotic Supplement to Mitigate Excessive Weight Gain Among Physicians in Residency
|
Phase 4 | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Completed |
NCT04117802 -
Effects of Maple Syrup on Gut Microbiota Diversity and Metabolic Syndrome
|
N/A | |
Completed |
NCT03697382 -
Effect of Daily Steps on Fat Metabolism
|
N/A | |
Completed |
NCT03241121 -
Study of Eating Patterns With a Smartphone App and the Effects of Time Restricted Feeding in the Metabolic Syndrome
|
N/A | |
Completed |
NCT04509206 -
Virtual Teaching Kitchen
|
N/A | |
Completed |
NCT05124847 -
TREating Pediatric Obesity
|
N/A |